Background Image
Table of Contents Table of Contents
Previous Page  48 / 74 Next Page
Information
Show Menu
Previous Page 48 / 74 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 5, September/October 2017

322

AFRICA

impairing bone marrow haematopoiesis are probably identical

to those that worsen the prognosis in CAD. These factors are

anaemia, iron deficiency, lipid disorders, chronic inflammation,

neurohumoral activation, glycaemic disturbance, vitamin D

3

deficiency, oxidative stress and renal failure.

17,18

Additionally,

red cell deformability diminution may result in impaired flow

through the microcirculation.

17

Previous studies have shown an association betweenRDWand

the severity of CAD.

11-13

Akin

et al

. investigated the association of

RDW with the severity of CAD in acute myocardial infarction

and showed that higher RDW values were correlated with higher

Syntax scores, which means more complex coronary lesions.

They found that after multiple logistic regression analysis, RDW

remained a significant predictor for the severity of CAD.

11

Isik

et al

. evaluated this relationship in patients with stable angina

pectoris and found an independent association between RDW

and the complexity of CAD, which was determined with Syntax

scores.

12

A large Chinese cohort study with 677 subjects showed

significantly elevated RDW values in CAD patients and a

positive correlation between RDW and the Gensini score.

13

They also found that a RDW value of 12.85% was an effective

cut-off point for predicting CAD, with a sensitivity of 50% and

a specificity of 65%. Recently, Sahin

et al

. concluded that RDW

values were independently associated with a high Syntax score

but were not associated with long-term mortality in patients with

non-ST-elevation myocardial infarction.

19

In agreement with the current literature, we found that

elevation in RDW values was associated with both the presence

and complexity of CAD. Furthermore, we found that an RDW

value of 13.25% was an effective cut-off point in order to

determine the presence of CAD. Moreover, our study is the first

to show an association between RDW and CAD severity in a

diabetic population.

Chronic inflammation and neurohumoral activation are

thought to be the key factors for both a worse cardiovascular

prognosis and more complex coronary lesions.

17,18

In our study,

hs-CRP levels were similar in the two CAD groups, but there was

a positive correlation between RDW and hs-CRP. Unfortunately,

we did not measure brain natriuretic peptides, which are markers

of the neurohumoral pathway. Some researchers demonstrated

that elevated mean platelet volume (MPV) was associated with

acute coronary syndromes, thrombosis and inflammation.

20,21

We

also found a positive relationship between RDW and MPV.

It is well known that there is a link between glycaemic

disturbance and high RDW values. Two different studies showed

a relationship between glycosylated haemoglobin and RDW

in an unselected elderly population and in healthy adults.

22,23

Garg

et al

. demonstrated that glycosylated haemoglobin was

an independent predictor of CAD severity in a non-diabetic

population.

24

Our findings support the results of previous studies.

This study has some limitations. First, we did not measure

some factors that might have influenced RDW levels, such as

vitamin B

12

, folate and iron levels. Second, cardiovascular events

were not analysed due to the cross-sectional nature of the study.

Third, the relationship between RDW, glycaemic disturbance

and the severity of CAD could have been better understood if

we had analysed glycosylated haemoglobin levels. Lastly, the

diagnosis of DM was based on a previous history instead of

biochemical results.

Conclusion

RDW values were significantly higher in diabetic than

non-diabetic patients with CAD. Higher RDW values were

related to more extensive and complex coronary lesions,

suggesting that RDW may be a marker for predicting CAD

severity in patients with DM.

References

1.

Perkins SL. Examination of blood and bone marrow. In: Greer

JP, Foerster J, Lukens JN, Rodgers GM, Paraksevas F, Glader BE,

(eds).

Wintrobe’s Clinical Hematology

, 11th edn. Salt Lake City, UT:

Lippincott Wilkins & Williams, 2003: 5–25.

2.

McKenzie SD. Introduction to anemia. In: McKenzie SD, (ed).

Clinical

Laboratory Hematology.

Saddle River, NJ: Pearson Prentice-Hall, 2003:

161–188.

3.

Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation

between red blood cell distribution width and cardiovascular event rate

in people with coronary disease.

Circulation

2008;

117

(2): 163–168.

PubMed PMID: 18172029.

4.

Al-Najjar Y, Goode KM, Zhang J, Cleland JG, Clark AL. Red cell

distribution width: an inexpensive and powerful prognostic marker in

heart failure.

Eur J Heart Fail

2009;

11

(12): 1155–1162. PubMed PMID:

19926599.

5.

Ye Z, Smith C, Kullo IJ. Usefulness of red cell distribution width to

predict mortality in patients with peripheral artery disease.

Am J Cardiol

2011;

107

(8): 1241–1245. PubMed PMID: 21296321.

6.

Perlstein TS, Weuve J, Pfeffer MA, Beckman JA. Red blood cell distribu-

tion width and mortality risk in a community–based prospective cohort.

Arch Intern Med

2009;

169

(6): 588–594. PubMed PMID: 19307522.

7.

Wilson PW. Diabetes mellitus and coronary heart disease.

Endocrinol

Metab Clin North Am

2001;

30

(4): 857–881. PubMed PMID: 11727403.

8.

Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors

for cardiovascular disease: the Framingham study.

Diabetes Care

1979;

2

(2): 120–126. PubMed PMID: 520114.

9.

Berry C, Tardif JC, Bourassa MG. Coronary heart disease in patients

with diabetes: part II: recent advances in coronary revascularization.

J

Am Coll Cardiol

2007;

49

(6): 643–656. PubMed PMID: 17291929.

10. Jacoby RM, Nesto RW. Acute myocardial infarction in the diabetic

patient: pathophysiology, clinical course and prognosis.

J Am Coll

Cardiol

1992;

20

(3): 736–744. PubMed PMID: 15123557.

11. Akin F, Köse N, Ayça B, Katkat F, Duran M, Uysal OK,

et al

. Relation

between red cell distribution width and severity of coronary artery

disease in patients with acute myocardial infarction.

Angiology

2013;

64

(8): 592–596. PubMed PMID: 23070683.

12. Isik T, Uyarel H, Tanboga IH, Kurt M, Ekinci M, Kaya A,

et al.

Relation of red cell distribution width with the presence, severity, and

complexity of coronary artery disease.

Coron Artery Dis

2012;

23

(1):

51–56. PubMed PMID: 22133925.

13. Ma FL, Li S, Li XL, Liu J, Qing P, Guo YL,

et al

. Correlation of red

cell distribution width with the severity of coronary artery disease: a

large Chinese cohort study from a single center.

Chin Med J

(Engl) 2013;

126

(6): 1053–1057. PubMed PMID: 23506577.

14. Gensini GG. A more meaningful scoring system for determining the

severity of coronary heart disease.

Am J Cardiol

1983;

51

(3): 606.

PubMed PMID: 6823874.

15. Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti

L. Red cell distribution width in heart failure: prediction of clinical

events and relationship with markers of ineffective erythropoiesis,

inflammation, renal function, and nutritional state.

Am Heart J

2009;